CORVUS PHARMACEUTICALS INC (CRVS)
US2210151005 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 12.62M | 13.20M | 63.50M | 16.50M | 5.20M | |||
| Marketable Securities | 14.53M | 29.10M | 6.00M | 27.80M | 72.80M | |||
| Receivables | 63.00K | 600.00K | 500.00K | 100.00K | 300.00K | |||
| Other Current Assets | 744.00K | 700.00K | 1.30M | 1.00M | 1.00M | |||
| Total Current Assets | 27.96M | 43.70M | 71.30M | 45.30M | 79.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.39M | 2.60M | 3.60M | 2.60M | 3.80M | |||
| Investments And Advances | 16.12M | 21.90M | 34.30M | 37.20M | N/A | |||
| Other Non-Current Assets | 89.00K | 100.00K | 200.00K | 400.00K | 500.00K | |||
| Total Non-Current Assets | 17.60M | 24.50M | 38.20M | 40.20M | 4.30M | |||
| TOTAL ASSETS | 45.55M | 68.20M | 109.50M | 85.50M | 83.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.34M | 8.80M | 8.10M | 8.70M | 7.80M | |||
| Accounts Payable | 1.52M | 2.00M | 1.60M | 3.50M | 2.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 6.87M | 10.80M | 9.70M | 12.10M | 10.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 1.40M | 2.60M | 1.20M | 2.30M | |||
| Total Non-Current Liabilities | 0.00 | 1.30M | 2.60M | 1.30M | 2.30M | |||
| TOTAL LIABILITIES | 6.87M | 12.10M | 12.30M | 13.40M | 12.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -334.72M | -307.70M | -266.40M | -223.10M | -217.10M | |||
| Additional Paid In Capital | 374.36M | 364.40M | 361.70M | 295.30M | 288.20M | |||
| Common Shares | 5.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -967.00K | -600.00K | 1.90M | 0.00 | 0.00 | |||
| Shares Outstanding | 49.04M | 46.60M | 46.60M | 28.40M | 28.00M | |||
| Tangible Book Value per Share | 0.79 | 1.20 | 2.09 | 2.54 | 2.54 | |||
| Total Shareholders' Equity | 38.68M | 56.10M | 97.20M | 72.10M | 71.10M | |||
| TOTAL LIABILITIES AND EQUITY | 45.55M | 68.20M | 109.50M | 85.50M | 83.60M | |||
| Statistics | ||||||||
| Current Ratio | 4.07 | 4.05 | 7.35 | 3.74 | 7.77 | |||
| Return On Assets (ROA) | -59.34% | -60.57% | -39.49% | -7.02% | -55.83% | |||
| Return On Equity (ROE) | -69.87% | -73.64% | -44.49% | -8.32% | -65.64% | |||
All data in USD